121 related articles for article (PubMed ID: 27331126)
1. Three cases of women with HPV-related squamous cell carcinoma of unknown primary in the pelvis and retroperitoneum: A case series.
Isbell A; Fields EC
Gynecol Oncol Rep; 2016 Apr; 16():5-8. PubMed ID: 27331126
[TBL] [Abstract][Full Text] [Related]
2. The role of human papilloma virus and p16 in occult primary of the head and neck: a comprehensive review of the literature.
Fotopoulos G; Pavlidis N
Oral Oncol; 2015 Feb; 51(2):119-23. PubMed ID: 25467774
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive management of HPV-related squamous cell carcinoma of the head and neck of unknown primary.
Rassy E; Nicolai P; Pavlidis N
Head Neck; 2019 Oct; 41(10):3700-3711. PubMed ID: 31301162
[TBL] [Abstract][Full Text] [Related]
4.
Cheol Park G; Roh JL; Cho KJ; Seung Kim J; Hyeon Jin M; Choi SH; Yuhl Nam S; Yoon Kim S
Int J Cancer; 2017 Mar; 140(6):1405-1412. PubMed ID: 27943271
[TBL] [Abstract][Full Text] [Related]
5. Extended field intensity modulated radiation therapy with concomitant boost for lymph node-positive cervical cancer: analysis of regional control and recurrence patterns in the positron emission tomography/computed tomography era.
Vargo JA; Kim H; Choi S; Sukumvanich P; Olawaiye AB; Kelley JL; Edwards RP; Comerci JT; Beriwal S
Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1091-8. PubMed ID: 25303889
[TBL] [Abstract][Full Text] [Related]
6. Primary retroperitoneal squamous cell carcinoma: a case report with review of the literature.
Matsuzaka Y; Yamaguchi K; Moriyoshi K; Takao Y; Takakura K; Konishi I
Int Cancer Conf J; 2019 Apr; 8(2):61-65. PubMed ID: 31149549
[TBL] [Abstract][Full Text] [Related]
7. Male pelvic squamous cell carcinoma of unknown primary origin.
Chiec L; Verma S; Kendler A; Abdel Karim N
Case Rep Oncol Med; 2014; 2014():953698. PubMed ID: 25478265
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant chemoradiation therapy with high-dose versus weekly cisplatin for resected, locally-advanced HPV/p16-positive and negative head and neck squamous cell carcinoma.
Geiger JL; Lazim AF; Walsh FJ; Foote RL; Moore EJ; Okuno SH; Olsen KD; Kasperbauer JL; Price DL; Garces YI; Ma DJ; Neben-Wittich MA; Molina JR; Garcia JJ; Price KA
Oral Oncol; 2014 Apr; 50(4):311-8. PubMed ID: 24467937
[TBL] [Abstract][Full Text] [Related]
10. HPV-Related Retroperitoneal Squamous Cell Carcinoma of Unknown Primary: A Case Report.
Oh HJ; Park EH; Lee YB; Hu J; Lee GJ; Chun SH; Lee MY; Lee DW; Kim J; Jin JY
Cancer Res Treat; 2015 Oct; 47(4):954-7. PubMed ID: 25687847
[TBL] [Abstract][Full Text] [Related]
11. Case Report: Combined pembrolizumab, 5-fluorouracil, and cisplatin therapy were remarkably effective in p16-positive squamous cell carcinoma of unknown primary.
Suzuki R; Hamada K; Ohkuma R; Homma M; Tsurui T; Iriguchi N; Ishiguro T; Hirasawa Y; Ariizumi H; Kubota Y; Horiike A; Yoshimura K; Wada S; Yamochi T; Tsunoda T
Front Oncol; 2023; 13():1231986. PubMed ID: 37496666
[TBL] [Abstract][Full Text] [Related]
12. T4 rectal cancer treated with preoperative chemoradiation to the posterior pelvis followed by multivisceral resection: patterns of failure and limitations of treatment.
Sanfilippo NJ; Crane CH; Skibber J; Feig B; Abbruzzese JL; Curley S; Vauthey JN; Ellis LM; Hoff P; Wolff RA; Brown TD; Cleary K; Wong A; Phan T; Janjan NA
Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):176-83. PubMed ID: 11516868
[TBL] [Abstract][Full Text] [Related]
13. Treatment outcomes in veterans with HPV-positive head and neck cancer.
Feinstein AJ; Shay SG; Chang E; Lewis MS; Wang MB
Am J Otolaryngol; 2017; 38(2):188-192. PubMed ID: 28342482
[TBL] [Abstract][Full Text] [Related]
14. Origin of cystic squamous cell carcinoma metastases in head and neck lymph nodes: Addition of EBV testing improves diagnostic accuracy.
Švajdler M; Kašpírková J; Hadravský L; Laco J; Dubinský P; Straka Ľ; Ondič O; Michal M; Skálová A
Pathol Res Pract; 2016 Jun; 212(6):524-31. PubMed ID: 27013059
[TBL] [Abstract][Full Text] [Related]
15. The prevalence of human papillomavirus in squamous cell carcinoma of unknown primary site metastatic to neck lymph nodes: a systematic review.
Boscolo-Rizzo P; Schroeder L; Romeo S; Pawlita M
Clin Exp Metastasis; 2015 Dec; 32(8):835-45. PubMed ID: 26358913
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors for head and neck cancer of unknown primary including the impact of human papilloma virus infection.
Axelsson L; Nyman J; Haugen-Cange H; Bove M; Johansson L; De Lara S; Kovács A; Hammerlid E
J Otolaryngol Head Neck Surg; 2017 Jun; 46(1):45. PubMed ID: 28601094
[TBL] [Abstract][Full Text] [Related]
17. Helical tomotherapy with simultaneous integrated boost after laparoscopic staging in patients with cervical cancer: analysis of feasibility and early toxicity.
Marnitz S; Köhler C; Burova E; Wlodarczyk W; Jahn U; Grün A; Budach V; Stromberger C
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e137-43. PubMed ID: 21600704
[TBL] [Abstract][Full Text] [Related]
18. Clinical response of pelvic and para-aortic lymphadenopathy to a radiation boost in the definitive management of locally advanced cervical cancer.
Rash DL; Lee YC; Kashefi A; Durbin-Johnson B; Mathai M; Valicenti R; Mayadev JS
Int J Radiat Oncol Biol Phys; 2013 Oct; 87(2):317-22. PubMed ID: 23906933
[TBL] [Abstract][Full Text] [Related]
19. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
20. Multi-institutional Observational Study of Prophylactic Extended-Field Concurrent Chemoradiation Therapy Using Weekly Cisplatin for Patients With Pelvic Node-Positive Cervical Cancer in East and Southeast Asia.
Wakatsuki M; Kato S; Ohno T; Banu PA; Hoang NC; Yadamsuren E; Supriana N; Cao J; Devi CRB; Calaguas MJ; Chansilpa Y; Cho CK; Adylkhanov T; Okonogi N; Nakano T; Tsujii H
Int J Radiat Oncol Biol Phys; 2019 Sep; 105(1):183-189. PubMed ID: 31125594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
